Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation

Current Opinion in Neurobiology

Volumn 30, Issue 1, 2015, Pages 131-138

  Neale, Benjamin M ^a,b   Sklar, Pamela ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VOLTAGE GATED CALCIUM CHANNEL;

ALLELE; BIPOLAR DISORDER; CACNA1C GENE; CACNB2 GENE; CALCIUM SIGNALING; COPY NUMBER VARIATION; FMR1 GENE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC PARAMETERS; GENETIC RISK; GENETIC VARIABILITY; HERITABILITY; HUMAN; KCTD13 GENE; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; NONHUMAN; POLYGENIC RISK SCORE; POLYGENICITY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION TO DISEASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

BIPOLAR DISORDER; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; SCHIZOPHRENIA;

EID: 84937120796     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2014.12.001     Document Type: Review

References (63)

1. Kraepelin E., Barclay R.M., Robertson G.M. Dementia Praecox and Paraphrenia 1919, E. & S. Livingstone, Edinburgh.
2. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60:1187-1192.
3. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
4. Berrettini W.H. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000, 48:531-538.
5. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003, 60:497-502.
6. Levinson D.F., Levinson M.D., Segurado R., Lewis C.M. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part I: Methods and power analysis. Am J Hum Genet 2003, 73:17-33.
7. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II: Schizophrenia. Am J Hum Genet 2003, 73:34-48.
8. Segurado R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger J.I., Craddock N., DePaulo J.R., Baron M., Gershon E.S., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part III: Bipolar disorder. Am J Hum Genet 2003, 73:49-62.
9. Sachidanandam R., Weissman D., Schmidt S.C., Kakol J.M., Stein L.D., Marth G., Sherry S., Mullikin J.C., Mortimore B.J., Willey D.L., et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001, 409:928-933.
10. Thorisson G.A., Stein L.D. The SNP Consortium website: past, present and future. Nucleic Acids Res 2003, 31:124-127.
11. International HapMap C. The international HapMap project. Nature 2003, 426:789-796.
12. International HapMap C. A haplotype map of the human genome. Nature 2005, 437:1299-1320.
13. International HapMap C., Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
14. International Schizophrenia C. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
15. Levy D., Ronemus M., Yamrom B., Lee Y.H., Leotta A., Kendall J., Marks S., Lakshmi B., Pai D., Ye K., et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011, 70:886-897.
16. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
17. Ramos-Quiroga J.A., Sanchez-Mora C., Casas M., Garcia-Martinez I., Bosch R., Nogueira M., Corrales M., Palomar G., Vidal R., Coll-Tane M., et al. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. J Psychiatr Res 2014, 49:60-67.
18. Rees E., Walters J.T., Chambert K.D., O'Dushlaine C., Szatkiewicz J., Richards A.L., Georgieva L., Mahoney-Davies G., Legge S.E., Moran J.L., et al. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet 2014, 23:1669-1676.
19. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
20. Stefansson H., Meyer-Lindenberg A., Steinberg S., Magnusdottir B., Morgen K., Arnarsdottir S., Bjornsdottir G., Walters G.B., Jonsdottir G.A., Doyle O.M., et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 2014, 505:361-366.
21. Szatkiewicz J.P., O'Dushlaine C., Chen G., Chambert K., Moran J.L., Neale B.M., Fromer M., Ruderfer D., Akterin S., Bergen S.E., et al. Copy number variation in schizophrenia in Sweden. Mol Psychiatry 2014, 19:762-773.
22. Williams N.M., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R., Stefansson H., Stefansson K., Magnusson P., Gudmundsson O.O., et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
23. Group G.C.R., Manolio T.A., Rodriguez L.L., Brooks L., Abecasis G., Ballinger D., Daly M., Donnelly P., Faraone S.V., et al. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet 2007, 39:1045-1051. Collaborative Association Study of P.
24. International Schizophrenia C., Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
25. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40:1053-1055.
26. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., Brant S.R., Silverberg M.S., Taylor K.D., Barmada M.M., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
27. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
28. Yang J., Manolio T.A., Pasquale L.R., Boerwinkle E., Caporaso N., Cunningham J.M., de Andrade M., Feenstra B., Feingold E., Hayes M.G., et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 2011, 43:519-525.
29. Cross-Disorder Group of the Psychiatric Genomics C., Lee S.H., Ripke S., Neale B.M., Faraone S.V., Purcell S.M., Perlis R.H., Mowry B.J., Thapar A., Goddard M.E., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013, 45:984-994.
30. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kahler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013, 45:1150-1159.
31. Schizophrenia Working Group of the Psychiatric Genomics C Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
32. Consortium E.P. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011, 9:e1001046.
33. Consortium E.P. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
34. Richards A.L., Jones L., Moskvina V., Kirov G., Gejman P.V., Levinson D.F., Sanders A.R., Molecular Genetics of Schizophrenia C, International Schizophrenia C, Purcell S., et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol Psychiatry 2012, 17:193-201.
35. Roussos P., Mitchell A.C., Voloudakis G., Fullard J.F., Pothula V.M., Tsang J., Stahl E.A., Georgakopoulos A., Ruderfer D.M., Charney A., et al. A role for noncoding variant in schizophrenia. Cell Rep 2014, 9:1417-1429. PMID: 25453756, Epub 2014 Nov 6. 10.1016/j.celrep.2014.10.015.
36. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008, 40:1056-1058.
37. Sklar P., Smoller J.W., Fan J., Ferreira M.A., Perlis R.H., Chambert K., Nimgaonkar V.L., McQueen M.B., Faraone S.V., Kirby A., et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008, 13:558-569.
38. Green E.K., Hamshere M., Forty L., Gordon-Smith K., Fraser C., Russell E., Grozeva D., Kirov G., Holmans P., Moran J.L., et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry 2013, 18:1302-1307.
39. Mendenhall E.M., Williamson K.E., Reyon D., Zou J.Y., Ram O., Joung J.K., Bernstein B.E. Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 2013, 31:1133-1136.
40. Chen D.T., Jiang X., Akula N., Shugart Y.Y., Wendland J.R., Steele C.J., Kassem L., Park J.H., Chatterjee N., Jamain S., et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 2013, 18:195-205.
41. Kirov G., Pocklington A.J., Holmans P., Ivanov D., Ikeda M., Ruderfer D., Moran J., Chambert K., Toncheva D., Georgieva L., et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012, 17:142-153.
42. Li B., Leal S.M. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 2008, 83:311-321.
43. Li B., Liu D.J., Leal S.M. Identifying rare variants associated with complex traits via sequencing. Curr Protoc Hum Genet 2013, Chapter 1:Unit 1.26.
44. Price A.L., Kryukov G.V., de Bakker P.I., Purcell S.M., Staples J., Wei L.J., Sunyaev S.R. Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 2010, 86:832-838.
45. Neale B.M., Rivas M.A., Voight B.F., Altshuler D., Devlin B., Orho-Melander M., Kathiresan S., Purcell S.M., Roeder K., Daly M.J. Testing for an unusual distribution of rare variants. PLoS Genet 2011, 7:e1001322.
46. Zuk O., Schaffner S.F., Samocha K., Do R., Hechter E., Kathiresan S., Daly M.J., Neale B.M., Sunyaev S.R., Lander E.S. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci U S A 2014, 111:E455-E464.
47. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kahler A., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
48. Veltman J.A., Brunner H.G. De novo mutations in human genetic disease. Nat Rev Genet 2012, 13:565-575.
49. Ng S.B., Bigham A.W., Buckingham K.J., Hannibal M.C., McMillin M.J., Gildersleeve H.I., Beck A.E., Tabor H.K., Cooper G.M., Mefford H.C., et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010, 42:790-793.
50. Power R.A., Kyaga S., Uher R., MacCabe J.H., Langstrom N., Landen M., McGuffin P., Lewis C.M., Lichtenstein P., Svensson A.C. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry 2013, 70:22-30.
51. McCarthy S.E., Gillis J., Kramer M., Lihm J., Yoon S., Berstein Y., Mistry M., Pavlidis P., Solomon R., Ghiban E., et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry 2014, 19:652-658.
52. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
53. Xu B., Ionita-Laza I., Roos J.L., Boone B., Woodrick S., Sun Y., Levy S., Gogos J.A., Karayiorgou M. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 2012, 44:1365-1369.
54. Gulsuner S., Walsh T., Watts A.C., Lee M.K., Thornton A.M., Casadei S., Rippey C., Shahin H., Consortium on the Genetics of S, Group PS, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013, 154:518-529.
55. Girard S.L., Gauthier J., Noreau A., Xiong L., Zhou S., Jouan L., Dionne-Laporte A., Spiegelman D., Henrion E., Diallo O., et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011, 43:860-863.
56. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011, 43:977-983. Psychiatric GCBDWG.
57. Splawski I., Timothy K.W., Decher N., Kumar P., Sachse F.B., Beggs A.H., Sanguinetti M.C., Keating M.T. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A 2005, 102:8089-8096. (discussion 8086-8088).
58. Rosenberg S.S., Spitzer N.C. Calcium signaling in neuronal development. Cold Spring Harb Perspect Biol 2011, 3:a004259.
59. Golzio C., Willer J., Talkowski M.E., Oh E.C., Taniguchi Y., Jacquemont S., Reymond A., Sun M., Sawa A., Gusella J.F., et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 2012, 485:363-367.
60. Callan M.A., Zarnescu D.C. Heads-up: new roles for the fragile X mental retardation protein in neural stem and progenitor cells. Genesis 2011, 49:424-440.
61. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
62. Schadt E.E., Bjorkegren J.L. NEW: network-enabled wisdom in biology, medicine, and health care. Sci Transl Med 2012, 4:115rv111.
63. Marin O., Valiente M., Ge X., Tsai L.H. Guiding neuronal cell migrations. Cold Spring Harb Perspect Biol 2010, 2:a001834.